FDAnews
www.fdanews.com/articles/87854-teijin-pharma-sato-pharmaceutical-jointly-introduce-antipsoriatic-agent-bonalfa

TEIJIN PHARMA, SATO PHARMACEUTICAL JOINTLY INTRODUCE ANTIPSORIATIC AGENT BONALFA

June 26, 2006

Teijin Pharma and Sato Pharmaceutical jointly announced on June 26 that they will begin marketing Bonalfa High Lotion 20 mu-g/g (tacalcitol), an ethical agent for treating psoriasis vulgaris, on June 27.

JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=12772)